JMS SKIMSPub Date : 2022-07-06DOI: 10.33883/jms.v25i2.1204
T. M. Malla, A. Najar, S. Masoodi, Z. Shah
{"title":"Cytogenetics: a reliable tool for the diagnosis and prognosis of hematological malignancies","authors":"T. M. Malla, A. Najar, S. Masoodi, Z. Shah","doi":"10.33883/jms.v25i2.1204","DOIUrl":"https://doi.org/10.33883/jms.v25i2.1204","url":null,"abstract":"Aim: The current review aims to provide a holistic overview of the cytogenetic techniques used to diagnose and diagnose haematological malignancies. \u0000Background: Since the discovery of the Philadelphia chromosome as a sole abnormality for diagnosing chronic myeloid leukaemia, cytogenetics has been widely used to diagnose malignancies in blood. With the introduction of advanced cytogenetic techniques like Fluorescent In-Situ Hybridization, Spectral Karyotyping and Comparative Genomic Hybridization, identification of clones and monitoring the response to drug therapy has now become easy as these have overcome the challenges of conventional cytogenetics like culture failures, poor morphology of chromosomes and low mitotic index. \u0000Review results: Ample evidence suggests that chromosomal aberrations are critical early indicators of progressing to a hematopoietic disorder. Conventional cytogenetics augmented with molecular cytogenetic techniques, immunophenotyping and real-time PCR not only aids in identifying specific clones but also characterizes haematological malignancies, predicting and assessing the minimal residual disease status during their management. \u0000Conclusion: We conclude that in this era of array diagnostics, cytogenetic techniques are still reliable for accurate diagnoses, characterization and prognosis of haematological malignancies. \u0000Clinical Significance: The present review discusses the role of cytogenetic tools in the diagnoses and prognosis of various haematological malignancies. It also provides an insight into the technical challenges encountered while performing these studies and the considerations to overcome them.","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128304975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2020-09-03DOI: 10.33883/jms.v23i3.751
S. Anand, Owais Ahmed, Vijay Kumar Kundal
{"title":"Clinical spectrum and out comes of snake bite patients admitted in a tertiary care hospital , A prospective observational hospital based study","authors":"S. Anand, Owais Ahmed, Vijay Kumar Kundal","doi":"10.33883/jms.v23i3.751","DOIUrl":"https://doi.org/10.33883/jms.v23i3.751","url":null,"abstract":"Background: Snakebite is a major public health problem and its prevalence is high in India. Insufficient epidemiological data and global neglect of this condition prompted the World Health organization to recognize it as a ‘‘neglected tropical disease’’ \u0000Objective: To study demographic characteristics of snakebite victims, to see clinical symptoms of bite and outcomes of snakebite. \u0000Methods: A prospective observational hospital-based study carried out from November 2016 to October 2017, in patients with a history of snakebite. \u0000Results:Total 300 patients were included in this study,170 (56.67%) were bitten by heamotoxic snakes and 130 (43.33%) were bitten by neurotoxic snakes. Majority of patients were in the age group of 20-39 years ( n=153; 51%). Men outnumbered women( n=190; 63.33%), with male to female ratio of 1.7: 1. Higher incidence of snake bite was found in July – September (n=135;45.00 %) followed by April to June( n=124; 41.33%).Majority of patients were farmers in rural areas ( n=242; 80.80%).Out of 300 patients,80required ICU care.In patients with neuroparalytic snake bites, clinical features were; ptosis (n=126; 96.92%),ophthalmoplegia (n=98; 75.38%),respiratory paralysis (n=60; 46.15%),bulbar weakness ( n=74; 56.92%) andabdomen pain(n=25; 19.23%).Clinical features in patients of haemotoxic snake bites were ; bleeding from bite site(n=110; 65.29%) , cellulitis(n=100; 58.82%), gum bleed(n=53; 31.18%), ecchymosis(n=49; 28.82%),epistaxis(n=27; 15.82%),gastrointestinal bleeding(n=25; 14.71%) andhaemoptysis(n=19; 11.18%). Complications observed were acute kidney injury ( n=62; 20.67%) , respiratory failure ( n=51; 17.00%) , DIC( n=7; 2.33%) and ARDS( n=5; 1.67%) . Out of 170 hemotoxic snake bite patients, 157 (92.35%) patients recovered and 13 (7.65%) patients died and out of 130 neurotoxic snake bites, 124 (95.39%) patients recovered and 6 (4.61%) patients died, overall mortality was 6.3%. In our study, bite to needle time was less than 1 hour in 47 patients (15.66%), less than 6 hrs in 120 patients (40%) and more than 24 hours in 45 (15%). \u0000Conclusion: Snakebite is common in adult males between 20 to 50 years and the commonest site is the lower limb. The majority of the victims are farmers who work in fields. A maximum number of cases presented within 1-6 hours of bite using a tourniquet on the affected limb as first aid. The complications and mortality of snakebite are high.","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"88 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128627860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2020-09-01DOI: 10.33883/jms.v23i3.778
P. Baba, A. Wani
{"title":"NASAL RECONSTRUCTION","authors":"P. Baba, A. Wani","doi":"10.33883/jms.v23i3.778","DOIUrl":"https://doi.org/10.33883/jms.v23i3.778","url":null,"abstract":"A 65 year male presented with squamous cell carcinoma of left side of nose.","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131753359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2020-08-22DOI: 10.33883/jms.v23i2.775
S. Masoodi
{"title":"NEWS & VIEWS","authors":"S. Masoodi","doi":"10.33883/jms.v23i2.775","DOIUrl":"https://doi.org/10.33883/jms.v23i2.775","url":null,"abstract":"\u0000The World Health Organisation (WHO): https://www.who.int/emergencies/diseases/novel-coronavirus-2019 \u0000The Centers for Disease Control and Prevention (CDC): https://www.coronavirus.gov. \u0000The National Institutes of Health (NIH): https://www.nih.gov/coronavirus. \u0000The National Center for Biotechnology Information (NCBI): https://www.ncbi.nlm.nih.gov/sars-cov-2/. \u0000The New England Journal of Medicine (NEJM): https://www.nejm.org/coronavirus \u0000The Lancet: https://www.thelancet.com/coronavirus \u0000British Medical Journal (BMJ): https://www.bmj.com/coronavirus \u0000Journal of American Medical Association (JAMA): https://jamanetwork.com/journals/jama/pages/coronavirus-alert \u0000Royal College for Physicians (Edinburgh): https://www.rcpe.ac.uk/covid-19-hub \u0000American College for Physicians (ACP): https://www.acponline.org/clinical-information/clinical-resources-products/coronavirus-disease-2019-covid-19-information-for-internists \u0000UpToDate: https://www.uptodate.com/home/covid-19-access \u0000Indian Council of Medical Research (ICMR): https://www.icmr.gov.in/ \u0000","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126816052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2020-06-29DOI: 10.33883/jms.v23i2.762
N. Wani
{"title":"Hepatitis C Virus Infection","authors":"N. Wani","doi":"10.33883/jms.v23i2.762","DOIUrl":"https://doi.org/10.33883/jms.v23i2.762","url":null,"abstract":" \u0000 \u0000Hepatitis C Virus Infection \u0000I have read with great interest the review entitled “Hepatitis C Virus Infection: A Brief Review” recently published by Saleem Kamili and Hisham Qadri in JMS, SKIMS (Vol 23 No 1 (2020): Jan-Mar).Useful information has been presented and these efforts will definitely help the clinicians to treat Hepatitis C patients in a better and effective way. I wish to make the following comments on the diagnostic evaluation of Hepatitis C infection. This was need of an hour to know the prevalence, causes, symptoms and available treatment of this disorder. As we know the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. New HCV infections are usually asymptomatic. Some persons get acute hepatitis which does not lead to a life-threatening disease. It is important to note here that around 30% (15–45%) of infected persons spontaneously clear the virus within 6 months of infection without any treatment. The remaining 70% (55–85%) of persons will develop chronic HCV infection. Of those with chronic HCV infection, the risk of cirrhosis ranges between 15% and 30% within 20 years. Globally, an estimated 71 million people have chronic hepatitis C virus infection. WHO estimated that in 2016, approximately 399 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma primary liver cancer).Antiviral medicines can cure more than 95% of persons with hepatitis C infection, thereby reducing the risk of death from cirrhosis and liver cancer, but access to diagnosis and treatment is low. \u0000 \u0000 \u0000 \u0000 ","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129303799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2020-06-05DOI: 10.33883/jms.v23i1.753
S. Kamili, Hisham Qadri
{"title":"Hepatitis C Virus Infection: A Brief Review","authors":"S. Kamili, Hisham Qadri","doi":"10.33883/jms.v23i1.753","DOIUrl":"https://doi.org/10.33883/jms.v23i1.753","url":null,"abstract":"Hepatitis C, caused by hepatitis C virus (HCV) was originally described as parenterally transmitted non-A non-B hepatitis. Since its discovery in 1989, the field of HCV research has become a shining example of successful translation of basic research wherein in a short of span of just 30 years the virus was discovered, highly sensitive and specific diagnostic assays were developed, epidemiology and clinical characteristics of the disease were well defined and now with the availability of highly efficacious antiviral therapies many countries are already on their way to achieving World Health Organization’s (WHO) elimination targets of hepatitis C by 2030. However, much work needs to be done to eliminate hepatitis C especially in resource poor countries. Most recent data show an estimated 71 million people are currently infected with HCV worldwide and approximately 400,000 people die each year from causes related to HCV. Of these estimates, more than 13 million HCV infected persons are in India and Pakistan (Figure 1). Despite the availability of a cure for hepatitis C, only 20% of those infected patients have been diagnosed (1). In order to achieve the WHO targets of hepatitis C elimination, concerted efforts will have to made to make affordable and reliable diagnostics available worldwide.","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"169 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126741306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2020-06-01DOI: 10.33883/jms.v23i1.741
S. Wani, Talib Khan, Zaka Sameen Khan, A. Najmi, T. Malik, Ishtiyaq Ahmad, M. Lone, F. Afroz, N. Khan
{"title":"Nutrition in Cancer –Practical Perspective","authors":"S. Wani, Talib Khan, Zaka Sameen Khan, A. Najmi, T. Malik, Ishtiyaq Ahmad, M. Lone, F. Afroz, N. Khan","doi":"10.33883/jms.v23i1.741","DOIUrl":"https://doi.org/10.33883/jms.v23i1.741","url":null,"abstract":"The syndrome of Cancer cachexia is characterised by an involuntary, sustained loss of weight and skeletal muscle mass, which negatively affects patients’ evolution and their quality of life, increasing the incidence of infection, hospital stay and mortality. The proportion of patients who present weight loss at diagnosis varies between 15 and 40% and may go up to 70 % depending on the type, stage of cancer and disease course. Patients with tumours of the gastrointestinal tract, head and neck, liver and lung cancers are at high risk for malnutrition (de las Peñas R), (Arends).","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"88 17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130770237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2019-12-19DOI: 10.33883/jms.v22i3.500
M. Wani, I. Wani
{"title":"Chronic Kidney Disease –Mineral Bone Disorder (CKD- MBD) – Further Insight at the Indian patients.","authors":"M. Wani, I. Wani","doi":"10.33883/jms.v22i3.500","DOIUrl":"https://doi.org/10.33883/jms.v22i3.500","url":null,"abstract":"The kidneys play an important role in maintaining normal serum calcium (Ca) and phosphorous (P) concentrations. Chronic kidney disease (CKD) is associated with significant disturbances in bone and mineral metabolism, leading to altered serum concentrations of Ca, P, vitamin D and parathyroid hormone (PTH)1,2,3. These changes are initially detected when the glomerular filtration rate (GFR) falls to ≤60 mL/min and are nearly uniform as GFR drops to <30ml/min2,3. This leads to a number of bone abnormalities previously called “renal osteodystrophy”, renamed as CKD-Mineral Bone Disorder (CKD-MBD) by National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI) consensus group4 . CKD-MBD is a systemic disorder manifested by either one or a combination of a) abnormalities of Ca, P, PTH or vitamin D metabolism, b) abnormalities in bone turnover, mineralization, volume, linear growth or strength c) vascular or soft tissue calcification. This has over time been expanded to include left ventricular hypertrophy, hypertension, immune dysfunction and inflammation5,6. ","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132592247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2019-12-14DOI: 10.33883/jms.v22i3.495
C. Saldanha
{"title":"Preconception Counselling","authors":"C. Saldanha","doi":"10.33883/jms.v22i3.495","DOIUrl":"https://doi.org/10.33883/jms.v22i3.495","url":null,"abstract":"It is quite often than not that in our day to day busy clinical schedules, we see patients with a spectrum of typical and atypical clinical presentations, sifting through investigation reports, OPD cards, radiology films, and case file documents. There is nothing more disconcerting than the interruption of this train of clinical management of the patient when suddenly we see the “ pregnancy test: POSITIVE” report and with that typical incredulous look we give the patient, physician and patient are left with a grey zone of uncertainty and certain anxiety. It is up to us doctors to avoid these very “oops” moments and be comprehensively aware that in all our clinical and allied specialties, a couple or the individual partner who comes with reproductive potential is necessarily to be counseled about wellness and healthy outcomes with regard to getting pregnant and health implications therein. It is pertinent to say that such patients be counseled appropriately about treatment if they wish to conceive or to take the correct type of contraception if pregnancy is not intended or contraindicated.","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129054777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMS SKIMSPub Date : 2019-12-14DOI: 10.33883/jms.v22i2.499
A. Koul
{"title":"Antimicrobial susceptibility testing and the Clinician.","authors":"A. Koul","doi":"10.33883/jms.v22i2.499","DOIUrl":"https://doi.org/10.33883/jms.v22i2.499","url":null,"abstract":"The clinicians are confronted with infections in their daily practice, and most of the times they rely on national or international data available to treat these infections. Sometimes it works but sometimes organisms do not respond to antimicrobials due to a variety of factors. \u0000The data clinician applies is most of the time extrapolated from higher centers, centers of excellence in infectious diseases or he follows guidelines issued by various reputed organizations like WHO, CDC Atlanta, IDSA, NICE, etc. \u0000Algorithms followed by the medical fraternity in managing infections have been changing with the advent of automation or computerization. Infectious disease diagnostics and management too has been changing fast since the advent of antibiotics. At the same time, these precious molecules are being used inadvertently due to the lack of isolation of organisms. \u0000A few years back clinicians were perplexed with conflicting outcomes of various microbiologic results from different medical centers that used to rely on age-old diagnostics modalities in microbiology. \u0000One of the landmarks in modern medicine is the determination of susceptibility of a particular pathogen to select an antimicrobial drug with its adequate blood concentration. In vitro susceptibility of the organism to antibiotics remains a Herculean task. These tests need to properly sampled, stored, incubated, reproduced and accurately performed despite edgy clinician who intends to treat the infection on a war footing. \u0000The clinicians are confronted with infections in their daily practice, and most of the times they rely on national or international data available to treat these infections. Sometimes it works but sometimes organisms do not respond to antimicrobials due to a variety of factors. \u0000The data clinician applies is most of the time extrapolated from higher centers, centers of excellence in infectious diseases or he follows guidelines issued by various reputed organizations like WHO, CDC Atlanta, IDSA, NICE, etc. \u0000Algorithms followed by the medical fraternity in managing infections have been changing with the advent of automation or computerization. Infectious disease diagnostics and management too has been changing fast since the advent of antibiotics. At the same time, these precious molecules are being used inadvertently due to the lack of isolation of organisms. \u0000A few years back clinicians were perplexed with conflicting outcomes of various microbiologic results from different medical centers that used to rely on age-old diagnostics modalities in microbiology. \u0000One of the landmarks in modern medicine is the determination of susceptibility of a particular pathogen to select an antimicrobial drug with its adequate blood concentration. In vitro susceptibility of the organism to antibiotics remains a Herculean task. These tests need to properly sampled, stored, incubated, reproduced and accurately performed despite edgy clinician who intends to treat the infection on a war footing.","PeriodicalId":167562,"journal":{"name":"JMS SKIMS","volume":"80 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132996124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}